Claudia Bracaglia

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 85 publications

Hepatic Involvement in Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome: Clinical and Therapeutic Insights From 2 Cases.

Hepatic Involvement in Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome: Clinical and Therapeutic Insights From 2 Cases.

Journal: The Journal of rheumatology

Published: July 15, 2026

Clinical Features and Outcome Measures Across Still Disease (Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still Disease) Cohorts Worldwide: A Systematic Literature Review.

Clinical Features and Outcome Measures Across Still Disease (Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still Disease) Cohorts Worldwide: A Systematic Literature Review.

Journal: The Journal of rheumatology

Published: July 01, 2026

Clinical Features and Outcome Measures Across Still Disease (Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still Disease) Cohorts Worldwide: A Systematic Literature Review.

Clinical Features and Outcome Measures Across Still Disease (Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still Disease) Cohorts Worldwide: A Systematic Literature Review.

Journal: The Journal of rheumatology

Published: July 01, 2026

Speaking the same language: international cross-validation of emerging biomarkers for juvenile idiopathic arthritis and Still's Disease.

Speaking the same language: international cross-validation of emerging biomarkers for juvenile idiopathic arthritis and Still's Disease.

Journal: Pediatric rheumatology online journal

Published: December 10, 2025

Critical care outcomes of hemophagocytic lymphohistiocytosis in children: a single centre retrospective observational study.

Critical care outcomes of hemophagocytic lymphohistiocytosis in children: a single centre retrospective observational study.

Journal: Pediatric rheumatology online journal

Published: November 26, 2025

Clinical Features and Outcome Measures Across Still Disease (Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still Disease) Cohorts Worldwide: A Systematic Literature Review.

Clinical Features and Outcome Measures Across Still Disease (Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still Disease) Cohorts Worldwide: A Systematic Literature Review.

Journal: The Journal of rheumatology

Published: September 17, 2025

Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases.

Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases.

Journal: Nature medicine

Published: August 19, 2025

Interleukin-18 Levels Are Associated With Disease Course in Patients With Still Disease Treated With Interleukin-1 Inhibitors.

Interleukin-18 Levels Are Associated With Disease Course in Patients With Still Disease Treated With Interleukin-1 Inhibitors.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: August 11, 2025

Interleukin-18 levels are associated with disease course in patients with Still's disease treated with IL-1 inhibitors.

Interleukin-18 levels are associated with disease course in patients with Still's disease treated with IL-1 inhibitors.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: August 11, 2025

SIGLEC-1 expression on monocytes as a diagnostic biomarker in pediatric type I interferon-mediated diseases.

SIGLEC-1 expression on monocytes as a diagnostic biomarker in pediatric type I interferon-mediated diseases.

Journal: The Journal of allergy and clinical immunology

Published: July 31, 2025

Influenza vaccine uptake in juvenile idiopathic arthritis during the COVID-19 pandemic: a multi-centre cross-sectional study by PRES vaccination working party.

Influenza vaccine uptake in juvenile idiopathic arthritis during the COVID-19 pandemic: a multi-centre cross-sectional study by PRES vaccination working party.

Journal: Pediatric rheumatology online journal

Published: July 09, 2025

Safety of intravenous use of anakinra in pediatric inflammatory conditions: a retrospective multicenter study.

Safety of intravenous use of anakinra in pediatric inflammatory conditions: a retrospective multicenter study.

Journal: Pediatric rheumatology online journal

Published: May 23, 2025

Showing 1-12 of 85

Last Updated: 09/26/2026